The FDAs position is unambiguous: BPC-157 "lacks sufficient safety data and has not been shown to be safe or effective in humans." Key implications: Compounding pharmacies cannot legally compound medications containing BPC-157 under Section 503A or 503B Marketing with therapeutic claims violates federal law regardless of disclaimers Warning letters have been issued to companies marketing BPC-157 as a therapeutic agent WADA Prohibition The World Anti-Doping Agency classifies BPC-157 as a prohibited substance under class S0: Non-Approved Substances , effective January 2023
Send Inquiry You may like Related Industry Knowledge
Haiman CA, Hankinson SE, Vivo ID, Guillemette C, Ishibe N, Hunter DJ et al
After 3 sessions, I already see a glow! Usually 46 sessions for best results, depending on your skin condition
Our team creates accredited, high quality, financially accessible digital course content that effortlessly transforms the careers of Aesthetic Entrepreneurs, putting them on the right path to high cash months by learning new techniques, creating transformations that do the talking